Purinergic Signalling

2.5(top 20%)

impact factor

908(top 20%)

papers

25.5K(top 10%)

citations

70(top 10%)

h-index

2.6(top 20%)

impact factor

1.1K

all documents

27.2K

doc citations

118(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Cellular function and molecular structure of ecto-nucleotidases	Purinergic Signalling	2012	850
2	The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance	Purinergic Signalling	2006	795
3	Alkaline Phosphatases	Purinergic Signalling	2006	486
4	Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade	Purinergic Signalling	2005	456
5	Physiological roles for ecto-5’-nucleotidase (CD73)	Purinergic Signalling	2006	443
6	ATP synthesis and storage	Purinergic Signalling	2012	340
7	P2 receptors in cardiovascular regulation and disease	Purinergic Signalling	2008	309
8	Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8	Purinergic Signalling	2005	258
9	Purinergic signalling and cancer	Purinergic Signalling	2013	258
10	Vesicular and conductive mechanisms of nucleotide release	Purinergic Signalling	2012	254
11	Purinergic signalling and immune cells	Purinergic Signalling	2014	254
12	Purines 2008 Meeting 29 June – 2 July 2008, Copenhagen, Denmark	Purinergic Signalling	2008	243
13	CD39 and control of cellular immune responses	Purinergic Signalling	2007	233
14	ATP release from non-excitable cells	Purinergic Signalling	2009	202
15	Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses	Purinergic Signalling	2013	184
16	The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression	Purinergic Signalling	2018	184
17	Molecular and functional properties of P2X receptors—recent progress and persisting challenges	Purinergic Signalling	2012	181
18	Pathophysiology of astroglial purinergic signalling	Purinergic Signalling	2012	171
19	P2X ion channel receptors and inflammation	Purinergic Signalling	2016	170
20	Ecto-5’-nucleotidase: Structure function relationships	Purinergic Signalling	2006	159
21	The P2X7 receptor–pannexin connection to dye uptake and IL-1β release	Purinergic Signalling	2009	157
22	ATP release via anion channels	Purinergic Signalling	2005	154
23	Extracellular NAD and ATP: Partners in immune cell modulation	Purinergic Signalling	2007	152
24	The GDA1_CD39 superfamily: NTPDases with diverse functions	Purinergic Signalling	2011	139
25	The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease	Purinergic Signalling	2020	139
26	In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization	Purinergic Signalling	2012	137
27	Purinergic signalling in the urinary tract in health and disease	Purinergic Signalling	2014	137
28	Modulation of purinergic signaling by NPP-type ectophosphodiesterases	Purinergic Signalling	2006	130
29	P2X7 receptor: Death or life?	Purinergic Signalling	2005	126
30	P2X7: a growth-promoting receptor—implications for cancer	Purinergic Signalling	2009	124
31	A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes	Purinergic Signalling	2013	123
32	Cardiac purinergic signalling in health and disease	Purinergic Signalling	2015	115
33	Genetics of the P2X7 receptor and human disease	Purinergic Signalling	2009	114
34	P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells	Purinergic Signalling	2012	114
35	Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors	Purinergic Signalling	2015	111
36	Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer	Purinergic Signalling	2011	108
37	P2 receptors and platelet function	Purinergic Signalling	2011	108
38	Purinergic signalling in the musculoskeletal system	Purinergic Signalling	2013	104
39	Purinergic signalling and diabetes	Purinergic Signalling	2013	103
40	Roles of P2 receptors in glial cells: focus on astrocytes	Purinergic Signalling	2006	102
41	C terminus of the P2X7 receptor: treasure hunting	Purinergic Signalling	2011	102
42	Internalization and desensitization of adenosine receptors	Purinergic Signalling	2008	101
43	Development of selective agonists and antagonists of P2Y receptors	Purinergic Signalling	2009	101
44	P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways	Purinergic Signalling	2009	101
45	P2 receptor-mediated signaling in mast cell biology	Purinergic Signalling	2010	101
46	Adenosine A2A receptors in Parkinson’s disease treatment	Purinergic Signalling	2008	97
47	Purinergic receptors in the endocrine and exocrine pancreas	Purinergic Signalling	2008	92
48	LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia	Purinergic Signalling	2016	91
49	Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification	Purinergic Signalling	2006	90
50	P2Y receptors and pain transmission	Purinergic Signalling	2004	89

Scientometrics

Overviews

Citing Bodies

Purinergic Signalling

Top Articles